Kinsale Capital Down Here's: Why I’m Still Holding
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesKinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...
Recession fears are resurging, but your best move isn’t to panic. This guide explains why time in the market beats ti...
Nuclear energy is back on the radar as a reliable, scalable power source. This guide explains how a $5,000 investment...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...
The auto industry is changing fast, and big, cash-rich automakers may be overlooked. This guide explains why investor...
ASML delivered a powerhouse quarter that suggests AI infrastructure spending remains resilient. With Intel set to rep...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Harrow Health's Q1 2026 earnings transcript offers more than numbers—it reveals management's execution plan and what ...
The chatter around KLAC stock is loud, but smart investors want clarity. This guide breaks down why KLAC is in focus,...